OUR PRODUCTS

Our startup can provide the
preparation of molecules that can interfere with both messenger RNA and non-coding RNA, which can generally regulate nearby disease genes.

These therapies require several stages, including the design of the inhibitory molecule, its synthesis in the laboratory, and encapsulation in nanoparticles or other carriers for administration in cells or preclinical models. We are applying for a patent to protect our proprietary AI-powered RNA modifying molecule discovery platform.